Literature DB >> 31966840

Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.

Fangfang Guo1,2, Xueqi Fu1, Jili Yang2, Xueying Zhang2, Dezhi Liu2, Wenjuan Feng2, Jinyu Liu2, Jinhong Qi2, Huifang Cao2, Li Qi3, Jingyuan Ren2.   

Abstract

Cervical cancer is a kind of female malignant tumor with increasing incidence recently. Macrophage migration inhibitory factor (MIF) is a major tumor facilitating factor. The previous study suggests that there was a correlation between MIF and migration or invasion of tumors. Epithelial mesenchymal transition (EMT) is the basis for tumor invasion and migration. Therefore, this study utilized MFI to treat cervical carcinoma Hela cells, and the mechanism of EMT was also further analyzed. Cervical carcinoma Hela cells were transfected with pFenesil MIF siRNA plasmids, following by real-time fluorescent quantitative PCR to detect MIF levels. MTT assay was then utilized for evaluate the proliferative activity of Hela cells after transfection. The cell invasion and migration were examined. The expression of E-cadherin and Vimentin were also detected. The results indicated that the MIF was positively expressed in Hela cells, whose MIF mRNA level was increased after the transfection (P<0.05). Compared to the control or blank group, the transfected group had elevated proliferative activity with elongated incubation time (P<0.05). Both invasion and migration functions of transfected cells were significantly potentiated (P<0.05) compared to the control or blank group. E-cadherin expression level was also decreased in experimental group. MIF was also expressed in cervical carcinoma Hela cells. Elevated MIF level could facilitate the cell invasion and migration, and elevate the Vimentin and decrease E-cadherin expression, thus facilitating EMT. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Hela cells; Macrophage migration inhibitory factor; cervical carcinoma; epithelial-mesenchymal transition

Year:  2017        PMID: 31966840      PMCID: PMC6965983     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

Review 1.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

Authors:  Stefan Grünert; Martin Jechlinger; Hartmut Beug
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

2.  Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.

Authors:  Naotake Funamizu; Chaoxin Hu; Curtis Lacy; Aaron Schetter; Geng Zhang; Peijun He; Jochen Gaedcke; Michael B Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Jeffrey Subleski; Tim Chan; Jonathan M Weiss; Timothy C Back; Katsuhiko Yanaga; Nader Hanna; H Richard Alexander; Anirban Maitra; S Perwez Hussain
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

3.  Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas.

Authors:  Kousuke Yoshinaga; Kiyoshi Ito; Takuya Moriya; Satoru Nagase; Tadao Takano; Hitoshi Niikura; Hironobu Sasano; Nobuo Yaegashi; Yasufumi Sato
Journal:  Cancer Sci       Date:  2010-12-22       Impact factor: 6.716

Review 4.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

5.  Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.

Authors:  Eva Fernebro; Pär-Ola Bendahl; Michael Dictor; Annette Persson; Mårten Fernö; Mef Nilbert
Journal:  Int J Cancer       Date:  2004-10-10       Impact factor: 7.396

Review 6.  EMT in cervical cancer: its role in tumour progression and response to therapy.

Authors:  Rehana Qureshi; Himanshu Arora; M A Rizvi
Journal:  Cancer Lett       Date:  2014-09-30       Impact factor: 8.679

7.  Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1.

Authors:  Guoying Lao; Ping Liu; Qiongwei Wu; Wenying Zhang; Yu Liu; Longtao Yang; Chengbin Ma
Journal:  Tumour Biol       Date:  2014-08-26

8.  Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer.

Authors:  C Kosmas; N Mylonakis; G Tsakonas; G Vorgias; N Karvounis; N Tsavaris; T Daladimos; N Kalinoglou; N Malamos; T Akrivos; A Karabelis
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

9.  MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.

Authors:  Na Liu; Ning Jiang; Rui Guo; Wei Jiang; Qing-Mei He; Ya-Fei Xu; Ying-Qin Li; Ling-Long Tang; Yan-Ping Mao; Ying Sun; Jun Ma
Journal:  Mol Cancer       Date:  2013-10-20       Impact factor: 27.401

10.  Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.

Authors:  Xiao-Hui Huang; Wei-Hua Jian; Zhao-Feng Wu; Jie Zhao; Hua Wang; Wen Li; Jin-Tang Xia
Journal:  Oncotarget       Date:  2014-07-30
View more
  1 in total

1.  Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.

Authors:  Martyna Parol-Kulczyk; Arkadiusz Gzil; Joanna Maciejewska; Magdalena Bodnar; Dariusz Grzanka
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.